Evolv Technologies Holdings, Inc. (EVLV) Q1 2025 Earnings Call Transcript

Evolv Technologies (EVLV) reported Q1 2025 revenue of $32 million, a 44% year-over-year increase, and ARR grew 34% to $106 million. The company welcomed over 50 new customers, bringing the total to 950, and reported positive adjusted EBITDA of $1.7 million, or a 5% margin. Looking ahead, Evolv expects revenue growth of 20% to 25% for 2025, projecting revenues between $125 million and $130 million, and anticipates achieving positive full-year adjusted EBITDA and cash flow positivity by year-end, driven by subscription growth and operational efficiencies.

Analysis

Evolv Technologies (EVLV) reported a solid start to fiscal 2025, with Q1 revenue reaching $32 million, a 44% year-over-year increase (off a soft Q1 2024 comparative) and a 10% sequential rise, alongside a 34% YoY growth in Annual Recurring Revenue (ARR) to $106 million. The company achieved positive adjusted EBITDA of $1.7 million, a 5.3% margin, a significant improvement from a $10.4 million loss in the prior year, signaling progress in operational efficiency despite approximately $1 million in one-time favorable revenue impacts. This performance comes as new leadership, including a new CEO and CFO, steers the company past recent challenges such as a resolved FTC inquiry and a revenue restatement, emphasizing enhanced controls and transparency. Key customer metrics remain robust, with over 50 new customers added (totaling approximately 950), strong retention rates (92% of eligible education customers post-FTC resolution), and significant expansion business, as 50% of Q1 booked units and ARR originated from existing clients. Management projects 20-25% revenue growth for FY2025 (to $125-$130 million), driven by its subscription model where approximately 78% of the revenue plan was underpinned by year-end 2024 ARR, and anticipates full-year positive adjusted EBITDA and year-end cash flow positivity. Initiatives like the new eXpedite product (12 customers signed) and a Certified Pre-Owned program are expected to contribute to growth, while a strategic shift towards more pure subscription deals, though beneficial for long-term ARR, is guided to present a 200-300 basis point headwind to 2025 gross margins. The company highlights a vast, largely untapped market opportunity, particularly in education and healthcare, where regulatory developments like California's new law mandating hospital weapons detection could provide further impetus.

Key Decisions for Investors

• Consider the company's ability to execute under new leadership and sustain growth momentum while managing its operational maturation following recent regulatory and financial reporting challenges.
• Account for the strategic shift towards pure subscription models, which bolsters long-term ARR but is guided to create a 200-300bps headwind to 2025 gross margins and may temper short-term revenue recognition.
• Closely monitor progress in key verticals like education and healthcare, particularly potential tailwinds from regulations such as California's new hospital security law, and the uptake of new initiatives like the eXpedite product and Certified Pre-Owned program.
• View the achievement of guided 20-25% revenue growth, full-year positive adjusted EBITDA, and year-end cash flow positivity for 2025 as critical indicators of the company's strategic execution and financial stabilization.